Evidence map›Paper›PMID 29628067›Full record

ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2018

Orbital and Medial Prefrontal Cortex Functional Connectivity of Major Depression Vulnerability and Disease.

Zoe Samara, Elisabeth A T Evers, Frenk Peeters, Harry B M Uylings, Grazyna Rajkowska, Johannes G Ramaekers, Peter Stiers

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Polygenic Risks for Depression and Neural Responses to Reward and Punishment in Young Adults.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Prefrontal cortex and depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Zoe SamaraDepartment of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands. Electronic address: zsamara@stanford.edu.
Elisabeth A T EversDepartment of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands.
Frenk PeetersDepartment of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands.
Harry B M UylingsDepartment of Anatomy and Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
Grazyna RajkowskaDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi.
Johannes G RamaekersDepartment of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands.
Peter StiersDepartment of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLAmsterdam UMC Location VUmc · NLUniversity of Mississippi Medical Center · US

Funding

Center for Psychiatric NeuroscienceP30GM103328 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI STOCKMEIER, CRAIG ALLEN · 2013 to 2017
$5.5M
NIGMS NIH HHS P30 GM103328
6 · The paper itself

Abstract

backgroundPathophysiology models of major depression (MD) center on the dysfunction of various cortical areas within the orbital and medial prefrontal cortex. While independent structural and functional abnormalities in these areas are consistent findings in MD, the complex interactions among them and the rest of the cortex remain largely unexplored.

methodsWe used resting-state functional magnetic resonance imaging connectivity to systematically map alterations in the communication between orbital and medial prefrontal cortex fields and the rest of the brain in MD. Functional connectivity (FC) maps from participants with current MD (n = 35), unaffected first-degree relatives (n = 36), and healthy control subjects (n = 38) were subjected to conjunction analyses to distinguish FC markers of MD vulnerability and FC markers of MD disease.

resultsFC abnormalities in MD vulnerability were found for dorsal medial wall regions and the anterior insula and concerned altered communication of these areas with the inferior parietal cortex and dorsal posterior cingulate, occipital areas and the brainstem. FC aberrations in current MD included the anterior insula, rostral and dorsal anterior cingulate cortex, and lateral orbitofrontal areas and concerned altered communication with the dorsal striatum, the cerebellum, the precuneus, the anterior prefrontal cortex, somatomotor cortex, dorsolateral prefrontal cortex, and visual areas in the occipital and inferior temporal lobes.

conclusionsFunctionally delineated parcellation maps can be used to identify putative connectivity markers in extended cortical regions such as the orbital and medial prefrontal cortex. The anterior insula and the rostral anterior cingulate cortex play a central role in the pathophysiology of MD, being consistently implicated both in the MD vulnerability and MD disease states.

Indexed as

AdultCerebral CortexDepressionFemaleGyrus CinguliHumansMagnetic Resonance ImagingMajor Depressive DisorderMaleMiddle AgedParietal LobePrefrontal CortexTemporal LobeFamily historyFunctional connectivityMajor depressionMRIPrefrontalVulnerability

Identifiers

PMID29628067
PMCPMC5894884
OpenAlexW2786176443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.